TXG
What one share of 10x Genomics holds
Laboratory Analytical Instruments
Our mission is to accelerate the mastery of biology to advance human health. We are a life sciences technology company focused on building innovative products and solutions to interrogate, understand and master biology. Our integrated research solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.
10x Genomics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.85 |
|---|---|
| Profit | −$0.59 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | $0.96 |
| Cash and investments | $3.87 |
| Book value | $6.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $6.13 | −$1.62 | $0.32 | −$1.25 | — | −$9.71 |
| 2018 | $10.93 | −$8.40 | $0.47 | −$6.17 | — | −$15.12 |
| 2019 | $6.29 | −$0.80 | $1.09 | −$0.21 | — | — |
| 2020 | $2.95 | −$5.37 | $0.36 | −$2.52 | — | $6.81 |
| 2021 | $4.44 | −$0.53 | $0.92 | −$1.11 | — | $7.27 |
| 2022 | $4.54 | −$1.46 | $1.16 | −$1.45 | — | $6.99 |
| 2023 | $5.28 | −$2.18 | $0.41 | −$0.54 | — | $6.22 |
| 2024 | $5.07 | −$1.52 | $0.10 | −$0.05 | — | $5.81 |
| 2025 | $5.15 | −$0.35 | $0.05 | $1.04 | — | $6.24 |